Tag Archives: TGA Complaint system

TGA new complaint system: compliance notices ineffective

Two outcomes (of 16) TGA complaints have now been received. AC-E7JS15BB/2018, submitted 3/8/18,  Brand Developers Australia Pty Ltd – Pain Erazor         https://www.youtube.com/watch?v=ye6s7qB-4Gc&feature=youtu.be “Pain Erazor” (ATG no: 276939) won a 2017 Choice “Shonky” award, was the subject of … Continue reading

Posted in Medical Devices, Pharmaceutical Promotion | Tagged , , , , , | 1 Comment

TGA’s new complaint system fails the Ease-a-cold test; Outcomes of Advertising Complaints Investigations Specification 2018 enacted

Stimulated by an article in today’s “The Conversation” on Pharmacare Laboratories Ease-a-Cold (below), I decided to try the TGA’s new complaint system.As I mentioned in a comment on this article, this product has been the subject of a previous article … Continue reading

Posted in Complementary medicine, Medicine policy, Pharmaceutical Promotion | Tagged , , , , , , | Leave a comment

TGA response to criticism of new complaint handling system; my comment

See: https://www.theguardian.com/australia-news/2018/jun/05/consumers-wont-know-about-dodgy-drug-ads-under-new-complaints-system-experts-warn The TGA media spokesperson said: “The new system will be more transparent than the previous one, apart from publication of TGA’s performance against key performance indicators detailed information on individual complaints will be published for medium-, serious- and critical-level … Continue reading

Posted in Complementary medicine, Pharmaceutical Promotion | Tagged , , , , , , , | Leave a comment